<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37140960</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-084X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2023</Year><Month>May</Month><Day>04</Day></PubDate></JournalIssue><Title>eLife</Title><ISOAbbreviation>Elife</ISOAbbreviation></Journal><ArticleTitle>Viral persistence, reactivation, and mechanisms of long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e86015</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.86015</ELocationID><Abstract><AbstractText>The COVID-19 global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has infected hundreds of millions of individuals. Following COVID-19 infection, a subset can develop a wide range of chronic symptoms affecting diverse organ systems referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID. A National Institutes of Health-sponsored initiative, RECOVER: Researching COVID to Enhance Recovery, has sought to understand the basis of long COVID in a large cohort. Given the range of symptoms that occur in long COVID, the mechanisms that may underlie these diverse symptoms may also be diverse. In this review, we focus on the emerging literature supporting the role(s) that viral persistence or reactivation of viruses may play in PASC. Persistence of SARS-CoV-2 RNA or antigens is reported in some organs, yet the mechanism by which they do so and how they may be associated with pathogenic immune responses is unclear. Understanding the mechanisms of persistence of RNA, antigen or other reactivated viruses and how they may relate to specific inflammatory responses that drive symptoms of PASC may provide a rationale for treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5404-1997</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Julg</LastName><ForeName>Boris</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4687-9626</Identifier><AffiliationInfo><Affiliation>Infectious Diseases Division, Massachusetts General Hospital, Ragon Institute of Mass General, MIT and Harvard, Boston, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohandas</LastName><ForeName>Sindhu</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8397-6249</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradfute</LastName><ForeName>Steven B</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0002-1985-751X</Identifier><AffiliationInfo><Affiliation>Center for Global Health, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>RECOVER Mechanistic Pathways Task Force</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 HL141623</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI162223</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Elife</MedlineTA><NlmUniqueID>101579614</NlmUniqueID><ISSNLinking>2050-084X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">Reactivation</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">global health</Keyword><Keyword MajorTopicYN="N">immunology</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">viral persistence</Keyword></KeywordList><CoiStatement>BC, BJ, SM, SB No competing interests declared</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Sherif</LastName><ForeName>Zaki A</ForeName><Initials>ZA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Molecular Biology, Howard University College of Medicine, Washington, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gomez</LastName><ForeName>Christian R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Division of Lung Diseases, National Institutes of Health (NIH), National Heart Lung and Blood Institute (NHLBI), Bethesda, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Connors</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Division of Critical Care, Columbia University Vagelos College of Physicians and Surgeons and New York - Presbyterian Morgan Stanley Children's Hospital, New York, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Henrich</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Division of Experimental Medicine, University of California, San Francisco, San Francisco, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Reeves</LastName><ForeName>W Brian</ForeName><Initials>WB</Initials><AffiliationInfo><Affiliation>Department of Medicine, Joe R. and Teresa Lozano Long School of Medicine, University of Texas, San Antonio, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Coombs</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>NIH RECOVER Research Initiative: Patient representative, Bronx, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>NIH RECOVER Research Initiative: Patient representative, Bronx, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jagannathan</LastName><ForeName>Pras</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bime</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care &amp; Sleep Medicine, Department of Medicine, University of Arizona College of Medicine, Tucson, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Quinlan</LastName><ForeName>Erin Burke</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>National Center for Complementary and Integrative Health, National Institutes of Health, Bethesda, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Portman</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Seattle Children's Hospital, Division of Pediatric Cardiology, Department of Pediatrics, University of Washington, Seattle, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gennaro</LastName><ForeName>Maria Laura</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Public Health Research Institute and Department of Medicine, Rutgers New Jersey Medical School, Newark, United States.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rehman</LastName><ForeName>Jalees</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, University of Illinois, College of Medicine, Chicago, United States.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37140960</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pii">86015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acharya D, Liu G, Gack MU. Dysregulation of type I interferon responses in COVID-19. Nature Reviews. Immunology. 2020;20:397&#x2013;398. doi: 10.1038/s41577-020-0346-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0346-x</ArticleId><ArticleId IdType="pmc">PMC7249038</ArticleId><ArticleId IdType="pubmed">32457522</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilar-Bretones M, Westerhuis BM, Raadsen MP, de Bruin E, Chandler FD, Okba NM, Haagmans BL, Langerak T, Endeman H, van den Akker JP, Gommers DA, van Gorp EC, GeurtsvanKessel CH, de Vries RD, Fouchier RA, Rockx BH, Koopmans MP, van Nierop GP. Seasonal Coronavirus-specific B cells with limited SARS-Cov-2 cross-reactivity dominate the IgG response in severe COVID-19. The Journal of Clinical Investigation. 2021;131:e150613. doi: 10.1172/JCI150613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI150613</ArticleId><ArticleId IdType="pmc">PMC8553556</ArticleId><ArticleId IdType="pubmed">34499051</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand SP, Pr&#xe9;vost J, Nayrac M, Beaudoin-Bussi&#xe8;res G, Benlarbi M, Gasser R, Brassard N, Laumaea A, Gong SY, Bourassa C, Brunet-Ratnasingham E, Medjahed H, Gendron-Lepage G, Goyette G, Gokool L, Morrisseau C, B&#xe9;gin P, Martel-Laferri&#xe8;re V, Tremblay C, Richard J, Bazin R, Duerr R, Kaufmann DE, Finzi A. Longitudinal analysis of humoral immunity against SARS-Cov-2 spike in Convalescent individuals up to 8 months post-symptom onset. Cell Reports. Medicine. 2021;2:100290. doi: 10.1016/j.xcrm.2021.100290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100290</ArticleId><ArticleId IdType="pmc">PMC8097665</ArticleId><ArticleId IdType="pubmed">33969322</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson EM, Goodwin EC, Verma A, Arevalo CP, Bolton MJ, Weirick ME, Gouma S, McAllister CM, Christensen SR, Weaver J, Hicks P, Manzoni TB, Oniyide O, Ramage H, Mathew D, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, Alanio C, D&#x2019;Andrea K, Kuthuru O, Dougherty J, Pattekar A, Kim J, Han N, Apostolidis SA, Huang AC, Vella LA, Kuri-Cervantes L, Pampena MB, Betts MR, Wherry EJ, Meyer NJ, Cherry S, Bates P, Rader DJ, Hensley SE, UPenn COVID Processing Unit Seasonal human Coronavirus antibodies are boosted upon SARS-Cov-2 infection but not associated with protection. Cell. 2021;184:1858&#x2013;1864. doi: 10.1016/j.cell.2021.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.010</ArticleId><ArticleId IdType="pmc">PMC7871851</ArticleId><ArticleId IdType="pubmed">33631096</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvin AM, Fink K, Schmid MA, Cathcart A, Spreafico R, Havenar-Daughton C, Lanzavecchia A, Corti D, Virgin HW. A perspective on potential antibody-dependent enhancement of SARS-Cov-2. Nature. 2020;584:353&#x2013;363. doi: 10.1038/s41586-020-2538-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2538-8</ArticleId><ArticleId IdType="pubmed">32659783</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydillo T, Rombauts A, Stadlbauer D, Aslam S, Abelenda-Alonso G, Escalera A, Amanat F, Jiang K, Krammer F, Carratala J, Garc&#xed;a-Sastre A. Immunological Imprinting of the antibody response in COVID-19 patients. Nature Communications. 2021;12:3781. doi: 10.1038/s41467-021-23977-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23977-1</ArticleId><ArticleId IdType="pmc">PMC8213790</ArticleId><ArticleId IdType="pubmed">34145263</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannister BA. Post-infectious disease syndrome. Postgraduate Medical Journal. 1988;64:559&#x2013;567. doi: 10.1136/pgmj.64.753.559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.64.753.559</ArticleId><ArticleId IdType="pmc">PMC2428896</ArticleId><ArticleId IdType="pubmed">3074289</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilich T, Nelde A, Heitmann JS, Maringer Y, Roerden M, Bauer J, Rieth J, Wacker M, Peter A, H&#xf6;rber S, Rachfalski D, M&#xe4;rklin M, Stevanovi&#x107; S, Rammensee H-G, Salih HR, Walz JS. T cell and antibody Kinetics delineate SARS-Cov-2 peptides mediating long-term immune responses in COVID-19 Convalescent individuals. Science Translational Medicine. 2021;13:eabf7517. doi: 10.1126/scitranslmed.abf7517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf7517</ArticleId><ArticleId IdType="pmc">PMC8128286</ArticleId><ArticleId IdType="pubmed">33723016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, Boodman C, Bello A, Hedley A, Schiffman Z, Doan K, Bastien N, Li Y, Van Caeseele PG, Poliquin G. Predicting infectious severe acute respiratory syndrome Coronavirus 2 from diagnostic samples. Clinical Infectious Diseases. 2020;71:2663&#x2013;2666. doi: 10.1093/cid/ciaa638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa638</ArticleId><ArticleId IdType="pmc">PMC7314198</ArticleId><ArticleId IdType="pubmed">32442256</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassedy A, Parle-McDermott A, O&#x2019;Kennedy R. Virus detection: A review of the current and emerging molecular and immunological methods. Frontiers in Molecular Biosciences. 2021;8:637559. doi: 10.3389/fmolb.2021.637559.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.637559</ArticleId><ArticleId IdType="pmc">PMC8093571</ArticleId><ArticleId IdType="pubmed">33959631</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, Adamo S, Raeber ME, B&#xe4;chli E, Rudiger A, St&#xfc;ssi-Helbling M, Huber LC, Nilsson J, Held U, Puhan MA, Boyman O. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nature Communications. 2022;13:446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-Cov-2, SARS-Cov, and MERS-Cov viral load Dynamics, duration of viral shedding, and Infectiousness: A systematic review and meta-analysis. The Lancet. Microbe. 2021;2:e13&#x2013;e22. doi: 10.1016/S2666-5247(20)30172-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30172-5</ArticleId><ArticleId IdType="pmc">PMC7837230</ArticleId><ArticleId IdType="pubmed">33521734</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Hu Z, Yi C, Chi Y, Xiong Q, Tan CW, Yi Y, Wang LF. An unusual COVID-19 case with over four months of viral shedding in the presence of low neutralizing antibodies: A case report. Journal of Biomedical Research. 2020;34:470&#x2013;474. doi: 10.7555/JBR.34.20200099.</Citation><ArticleIdList><ArticleId IdType="doi">10.7555/JBR.34.20200099</ArticleId><ArticleId IdType="pmc">PMC7718073</ArticleId><ArticleId IdType="pubmed">33243942</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Song J, Liu H, Zheng H, Chen C. Positive Epstein-Barr virus detection in Coronavirus disease 2019 (COVID-19) patients. Scientific Reports. 2021;11:10902. doi: 10.1038/s41598-021-90351-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90351-y</ArticleId><ArticleId IdType="pmc">PMC8149409</ArticleId><ArticleId IdType="pubmed">34035353</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Deng Y, Pan D. Microrna regulation of human Herpesvirus latency. Viruses. 2022;14:1215. doi: 10.3390/v14061215.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14061215</ArticleId><ArticleId IdType="pmc">PMC9231095</ArticleId><ArticleId IdType="pubmed">35746686</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiale C, Greene TT, Zuniga EI. Interferon induction, evasion, and paradoxical roles during SARS-Cov-2 infection. Immunological Reviews. 2022;309:12&#x2013;24. doi: 10.1111/imr.13113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.13113</ArticleId><ArticleId IdType="pmc">PMC9350402</ArticleId><ArticleId IdType="pubmed">35775361</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho A, Muecksch F, Schaefer-Babajew D, Wang Z, Finkin S, Gaebler C, Ramos V, Cipolla M, Mendoza P, Agudelo M, Bednarski E, DaSilva J, Shimeliovich I, Dizon J, Daga M, Millard KG, Turroja M, Schmidt F, Zhang F, Tanfous TB, Jankovic M, Oliveria TY, Gazumyan A, Caskey M, Bieniasz PD, Hatziioannou T, Nussenzweig MC. Anti-SARS-Cov-2 receptor-binding domain antibody evolution after mRNA vaccination. Nature. 2021;600:517&#x2013;522. doi: 10.1038/s41586-021-04060-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04060-7</ArticleId><ArticleId IdType="pmc">PMC8674133</ArticleId><ArticleId IdType="pubmed">34619745</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark DV, Kibuuka H, Millard M, Wakabi S, Lukwago L, Taylor A, Eller MA, Eller LA, Michael NL, Honko AN, Olinger GG, Schoepp RJ, Hepburn MJ, Hensley LE, Robb ML. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: A retrospective cohort study. The Lancet. Infectious Diseases. 2015;15:905&#x2013;912. doi: 10.1016/S1473-3099(15)70152-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)70152-0</ArticleId><ArticleId IdType="pubmed">25910637</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausen TM, Sandoval DR, Spliid CB, Pihl J, Perrett HR, Painter CD, Narayanan A, Majowicz SA, Kwong EM, McVicar RN, Thacker BE, Glass CA, Yang Z, Torres JL, Golden GJ, Bartels PL, Porell RN, Garretson AF, Laubach L, Feldman J, Yin X, Pu Y, Hauser BM, Caradonna TM, Kellman BP, Martino C, Gordts PLSM, Chanda SK, Schmidt AG, Godula K, Leibel SL, Jose J, Corbett KD, Ward AB, Carlin AF, Esko JD. SARS-Cov-2 infection depends on cellular Heparan sulfate and Ace2. Cell. 2020;183:1043&#x2013;1057. doi: 10.1016/j.cell.2020.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.033</ArticleId><ArticleId IdType="pmc">PMC7489987</ArticleId><ArticleId IdType="pubmed">32970989</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen KW, Linderman SL, Moodie Z, Czartoski J, Lai L, Mantus G, Norwood C, Nyhoff LE, Edara VV, Floyd K, De Rosa SC, Ahmed H, Whaley R, Patel SN, Prigmore B, Lemos MP, Davis CW, Furth S, O&#x2019;Keefe JB, Gharpure MP, Gunisetty S, Stephens K, Antia R, Zarnitsyna VI, Stephens DS, Edupuganti S, Rouphael N, Anderson EJ, Mehta AK, Wrammert J, Suthar MS, Ahmed R, McElrath MJ. Longitudinal analysis shows durable and broad immune memory after SARS-Cov-2 infection with persisting antibody responses and memory B and T cells. Cell Reports. Medicine. 2021;2:100354. doi: 10.1016/j.xcrm.2021.100354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100354</ArticleId><ArticleId IdType="pmc">PMC8253687</ArticleId><ArticleId IdType="pubmed">34250512</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V, Mahajan A, Krishnamachary B, Spikes L, Chalise P, Dhillon NK. Persistent presence of spike protein and viral RNA in the circulation of individuals with post-acute sequelae of COVID-19. medRxiv. 2022 doi: 10.1101/2022.08.07.22278520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.07.22278520</ArticleId><ArticleId IdType="pmc">PMC10048846</ArticleId><ArticleId IdType="pubmed">36756925</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V, Mahajan A, Spikes L, Krishnamachary B, Ram AK, Kumar A, Chen L, Chalise P, Dhillon NK. Persistent circulation of soluble and extracellular Vesicle-linked spike protein in individuals with Postacute sequelae of COVID-19. Journal of Medical Virology. 2023;95:e28568. doi: 10.1002/jmv.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28568</ArticleId><ArticleId IdType="pmc">PMC10048846</ArticleId><ArticleId IdType="pubmed">36756925</ArticleId></ArticleIdList></Reference><Reference><Citation>Cromer D, Steain M, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, Kent SJ, Triccas JA, Khoury DS, Davenport MP. Neutralising antibody Titres as predictors of protection against SARS-Cov-2 variants and the impact of boosting: A meta-analysis. The Lancet. Microbe. 2022;3:e52&#x2013;e61. doi: 10.1016/S2666-5247(21)00267-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(21)00267-6</ArticleId><ArticleId IdType="pmc">PMC8592563</ArticleId><ArticleId IdType="pubmed">34806056</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G. Cross-reacting antibodies enhance Dengue virus infection in humans. Science. 2010;328:745&#x2013;748. doi: 10.1126/science.1185181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1185181</ArticleId><ArticleId IdType="pmc">PMC3837288</ArticleId><ArticleId IdType="pubmed">20448183</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Archives of Neurology. 2006;63:839&#x2013;844. doi: 10.1001/archneur.63.6.noc50328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.63.6.noc50328</ArticleId><ArticleId IdType="pubmed">16606758</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe &#xc5;, Abbondanza D, Fleming SJ, Subramanian A, Montoro DT, Jagadeesh KA, Dey KK, Sen P, Slyper M, Pita-Ju&#xe1;rez YH, Phillips D, Biermann J, Bloom-Ackermann Z, Barkas N, Ganna A, Gomez J, Melms JC, Katsyv I, Normandin E, Naderi P, Popov YV, Raju SS, Niezen S, Tsai LTY, Siddle KJ, Sud M, Tran VM, Vellarikkal SK, Wang Y, Amir-Zilberstein L, Atri DS, Beechem J, Brook OR, Chen J, Divakar P, Dorceus P, Engreitz JM, Essene A, Fitzgerald DM, Fropf R, Gazal S, Gould J, Grzyb J, Harvey T, Hecht J, Hether T, Jan&#xe9;-Valbuena J, Leney-Greene M, Ma H, McCabe C, McLoughlin DE, Miller EM, Muus C, Niemi M, Padera R, Pan L, Pant D, Pe&#x2019;er C, Pfiffner-Borges J, Pinto CJ, Plaisted J, Reeves J, Ross M, Rudy M, Rueckert EH, Siciliano M, Sturm A, Todres E, Waghray A, Warren S, Zhang S, Zollinger DR, Cosimi L, Gupta RM, Hacohen N, Hibshoosh H, Hide W, Price AL, Rajagopal J, Tata PR, Riedel S, Szabo G, Tickle TL, Ellinor PT, Hung D, Sabeti PC, Novak R, Rogers R, Ingber DE, Jiang ZG, Juric D, Babadi M, Farhi SL, Izar B, Stone JR, Vlachos IS, Solomon IH, Ashenberg O, Porter CBM, Li B, Shalek AK, Villani AC, Rozenblatt-Rosen O, Regev A. COVID-19 tissue atlases reveal sars-cov-2 pathology and cellular targets. Nature. 2021;595:107&#x2013;113. doi: 10.1038/s41586-021-03570-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, Verillaud B, Aparicio C, Wagner S, Gheusi G, Kergoat L, Kornobis E, Donati F, Cokelaer T, Hervochon R, Madec Y, Roze E, Salmon D, Bourhy H, Lecuit M, Lledo PM. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Science Translational Medicine. 2021;13:eabf8396. doi: 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, Chen L, Li M, Liu Y, Wang G, Yuan Z, Feng Z, Zhang Y, Wu Y, Chen Y. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (covid-19) Frontiers in Immunology. 2020;11:827. doi: 10.3389/fimmu.2020.00827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00827</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Drago F, Ciccarese G, Rebora A, Parodi A. Human Herpesvirus-6, -7, and Epstein-Barr virus reactivation in Pityriasis Rosea during COVID-19. Journal of Medical Virology. 2021;93:1850&#x2013;1851. doi: 10.1002/jmv.26549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26549</ArticleId><ArticleId IdType="pmc">PMC7537064</ArticleId><ArticleId IdType="pubmed">32970319</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y-Q, Xia M-H, Ren L, Zhang Y-F, Ao Q-L, Xu S-P, Kuang D, Liu Q, Yan B, Zhou Y-W, Chu Q, Liu L, Yang X-P, Wang G-P. Deficiency of Tfh cells and germinal center in deceased COVID-19 patients. Current Medical Science. 2020;40:618&#x2013;624. doi: 10.1007/s11596-020-2225-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11596-020-2225-x</ArticleId><ArticleId IdType="pmc">PMC7412778</ArticleId><ArticleId IdType="pubmed">32767259</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans JP, Zeng C, Carlin C, Lozanski G, Saif LJ, Oltz EM, Gumina RJ, Liu SL. Neutralizing antibody responses elicited by SARS-Cov-2 mRNA vaccination wane over time and are boosted by breakthrough infection. Science Translational Medicine. 2022;14:eabn8057. doi: 10.1126/scitranslmed.abn8057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abn8057</ArticleId><ArticleId IdType="pmc">PMC8939766</ArticleId><ArticleId IdType="pubmed">35166573</ArticleId></ArticleIdList></Reference><Reference><Citation>Files JK, Boppana S, Perez MD, Sarkar S, Lowman KE, Qin K, Sterrett S, Carlin E, Bansal A, Sabbaj S, Long DM, Kutsch O, Kobie J, Goepfert PA, Erdmann N. Sustained cellular immune dysregulation in individuals recovering from sars-cov-2 infection. The Journal of Clinical Investigation. 2021;131:e140491. doi: 10.1172/JCI140491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140491</ArticleId><ArticleId IdType="pmc">PMC7773371</ArticleId><ArticleId IdType="pubmed">33119547</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, Cipolla M, Viant C, Barnes CO, Bram Y, Breton G, H&#xe4;ggl&#xf6;f T, Mendoza P, Hurley A, Turroja M, Gordon K, Millard KG, Ramos V, Schmidt F, Weisblum Y, Jha D, Tankelevich M, Martinez-Delgado G, Yee J, Patel R, Dizon J, Unson-O&#x2019;Brien C, Shimeliovich I, Robbiani DF, Zhao Z, Gazumyan A, Schwartz RE, Hatziioannou T, Bjorkman PJ, Mehandru S, Bieniasz PD, Caskey M, Nussenzweig MC. Evolution of antibody immunity to SARS-Cov-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. 2021;10:763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Wang Y, Kang L, Hu Y, Wang L, Zhong J, Chen H, Ren L, Gu X, Wang G, Wang C, Dong X, Wu C, Han L, Wang Y, Fan G, Zou X, Li H, Xu J, Jin Q, Cao B, Wang J. Cross-reactive antibody against human Coronavirus Oc43 spike protein correlates with disease severity in COVID-19 patients: A retrospective study. Emerging Microbes &amp; Infections. 2021;10:664&#x2013;676. doi: 10.1080/22221751.2021.1905488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1905488</ArticleId><ArticleId IdType="pmc">PMC8023607</ArticleId><ArticleId IdType="pubmed">33734013</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nature Medicine. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Z, Wang G, Mao D, Zhang B, Li H, Zuo M, Zhao Z, Yen J. A novel method for food market regulation by emotional tendencies predictions from food reviews based on Blockchain and Saes. Foods. 2021;10:1398. doi: 10.3390/foods10061398.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods10061398</ArticleId><ArticleId IdType="pmc">PMC8234153</ArticleId><ArticleId IdType="pubmed">34204245</ArticleId></ArticleIdList></Reference><Reference><Citation>He H, Wang Y, Wu M, Sun B. Positive Epstein-Barr virus detection and mortality in respiratory failure patients admitted to the intensive care unit. The Clinical Respiratory Journal. 2017;11:895&#x2013;900. doi: 10.1111/crj.12433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/crj.12433</ArticleId><ArticleId IdType="pubmed">26663042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, M&#xfc;ller MA, Drosten C, P&#xf6;hlmann S. SARS-Cov-2 cell entry depends on Ace2 and Tmprss2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibarrondo FJ, Fulcher JA, Goodman-Meza D, Elliott J, Hofmann C, Hausner MA, Ferbas KG, Tobin NH, Aldrovandi GM, Yang OO. Rapid decay of anti-SARS-Cov-2 antibodies in persons with mild COVID-19. New England Journal of Medicine. 2020;383:1085&#x2013;1087. doi: 10.1056/NEJMc2025179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2025179</ArticleId><ArticleId IdType="pmc">PMC7397184</ArticleId><ArticleId IdType="pubmed">32706954</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarjour NN, Masopust D, Jameson SC. T cell memory: Understanding COVID-19. Immunity. 2021;54:14&#x2013;18. doi: 10.1016/j.immuni.2020.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.12.009</ArticleId><ArticleId IdType="pmc">PMC7749639</ArticleId><ArticleId IdType="pubmed">33406391</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplonek P, Wang C, Bartsch Y, Fischinger S, Gorman MJ, Bowman K, Kang J, Dayal D, Martin P, Nowak RP, Villani A-C, Hsieh C-L, Charland NC, Gonye ALK, Gushterova I, Khanna HK, LaSalle TJ, Lavin-Parsons KM, Lilley BM, Lodenstein CL, Manakongtreecheep K, Margolin JD, McKaig BN, Rojas-Lopez M, Russo BC, Sharma N, Tantivit J, Thomas MF, Sade-Feldman M, Feldman J, Julg B, Nilles EJ, Musk ER, Menon AS, Fischer ES, McLellan JS, Schmidt A, Goldberg MB, Filbin MR, Hacohen N, Lauffenburger DA, Alter G. Early cross-Coronavirus reactive signatures of humoral immunity against COVID-19. Science Immunology. 2021;6:eabj2901. doi: 10.1126/sciimmunol.abj2901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abj2901</ArticleId><ArticleId IdType="pmc">PMC8943686</ArticleId><ArticleId IdType="pubmed">34652962</ArticleId></ArticleIdList></Reference><Reference><Citation>Keita AK, Vidal N, Toure A, Diallo MSK, Magassouba N, Baize S, Mateo M, Raoul H, Mely S, Subtil F, Kpamou C, Koivogui L, Traore F, Sow MS, Ayouba A, Etard JF, Delaporte E, Peeters M, PostEbogui Study Group A 40-month follow-up of Ebola virus disease survivors in Guinea (Postebogui) reveals long-term detection of Ebola viral ribonucleic acid in Semen and breast milk. Open Forum Infectious Diseases. 2019;6:fz482. doi: 10.1093/ofid/ofz482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofz482</ArticleId><ArticleId IdType="pmc">PMC7047953</ArticleId><ArticleId IdType="pubmed">32128327</ArticleId></ArticleIdList></Reference><Reference><Citation>Keita AK, Koundouno FR, Faye M, D&#xfc;x A, Hinzmann J, Diallo H, Ayouba A, Le Marcis F, Soropogui B, Ifono K, Diagne MM, Sow MS, Bore JA, Calvignac-Spencer S, Vidal N, Camara J, Keita MB, Renevey A, Diallo A, Soumah AK, Millimono SL, Mari-Saez A, Diop M, Dor&#xe9; A, Soumah FY, Kourouma K, Vielle NJ, Loucoubar C, Camara I, Kourouma K, Annibaldis G, Bah A, Thielebein A, Pahlmann M, Pullan ST, Carroll MW, Quick J, Formenty P, Legand A, Pietro K, Wiley MR, Tordo N, Peyrefitte C, McCrone JT, Rambaut A, Sidib&#xe9; Y, Barry MD, Kourouma M, Saouromou CD, Cond&#xe9; M, Bald&#xe9; M, Povogui M, Keita S, Diakite M, Bah MS, Sidibe A, Diakite D, Sako FB, Traore FA, Ki-Zerbo GA, Lemey P, G&#xfc;nther S, Kafetzopoulou LE, Sall AA, Delaporte E, Duraffour S, Faye O, Leendertz FH, Peeters M, Toure A, Magassouba NF. Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks. Nature. 2021;597:539&#x2013;543. doi: 10.1038/s41586-021-03901-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03901-9</ArticleId><ArticleId IdType="pubmed">34526718</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH. Respiratory syncytial virus disease in infants despite prior administration of Antigenic Inactivated vaccine. American Journal of Epidemiology. 1969;89:422&#x2013;434. doi: 10.1093/oxfordjournals.aje.a120955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a120955</ArticleId><ArticleId IdType="pubmed">4305198</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Is human Herpesvirus-6 a trigger for chronic fatigue syndrome. Journal of Clinical Virology. 2006;37 Suppl 1:S39&#x2013;S46. doi: 10.1016/S1386-6532(06)70010-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(06)70010-5</ArticleId><ArticleId IdType="pubmed">17276367</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WS, Wheatley AK, Kent SJ, DeKosky BJ. Antibody-dependent Enhancement and SARS-Cov-2 vaccines and therapies. Nature Microbiology. 2020;5:1185&#x2013;1191. doi: 10.1038/s41564-020-00789-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-00789-5</ArticleId><ArticleId IdType="pubmed">32908214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehner GF, Klein SJ, Zoller H, Peer A, Bellmann R, Joannidis M. Correlation of Interleukin-6 with Epstein-Barr virus levels in COVID-19. Critical Care. 2020;24:657. doi: 10.1186/s13054-020-03384-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03384-6</ArticleId><ArticleId IdType="pmc">PMC7682685</ArticleId><ArticleId IdType="pubmed">33228750</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA. 2005;293:2496&#x2013;2500. doi: 10.1001/jama.293.20.2496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.293.20.2496</ArticleId><ArticleId IdType="pubmed">15914750</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, Doolman R, Asraf K, Mendelson E, Ziv A, Rubin C, Freedman L, Kreiss Y, Regev-Yochay G. Waning immune humoral response to BNT162b2 COVID-19 vaccine over 6 months. New England Journal of Medicine. 2021;385:e84. doi: 10.1056/NEJMoa2114583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2114583</ArticleId><ArticleId IdType="pmc">PMC8522797</ArticleId><ArticleId IdType="pubmed">34614326</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield KM, Watson RO, Schneider JM, Neff CP, Yamada E, Zhang M, Campbell TB, Falta MT, Jolley SE, Fontenot AP, Palmer BE. SARS-Cov-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute Sequalae of SARS-Cov-2. PLOS Pathogens. 2022;18:e1010359. doi: 10.1371/journal.ppat.1010359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WD, Chang SY, Wang JT, Tsai MJ, Hung CC, Hsu CL, Chang SC. Prolonged virus shedding even after seroconversion in a patient with COVID-19. The Journal of Infection. 2020;81:318&#x2013;356. doi: 10.1016/j.jinf.2020.03.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.063</ArticleId><ArticleId IdType="pmc">PMC7151379</ArticleId><ArticleId IdType="pubmed">32283147</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo TQ, Marston BJ, Dahl BA, De Cock KM. Ebola: Anatomy of an epidemic. Annual Review of Medicine. 2017;68:359&#x2013;370. doi: 10.1146/annurev-med-052915-015604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-052915-015604</ArticleId><ArticleId IdType="pubmed">27813879</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L, Liang W, Pang J, Xu G, Chen Y, Guo X, Wang X, Zhao Y, Lai Y, Liu Y, Li B, Su B, Zhang S, Baniyash M, Shen L, Chen L, Ling Y, Wang Y, Liang Q, Lu H, Zhang Z, Wang F. Dynamics of TCR repertoire and T cell function in COVID-19 Convalescent individuals. Cell Discovery. 2021;7:89. doi: 10.1038/s41421-021-00321-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00321-x</ArticleId><ArticleId IdType="pmc">PMC8476510</ArticleId><ArticleId IdType="pubmed">34580278</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, Sperhake JP, Schr&#xf6;der AS, Edler C, Mushumba H, Fitzek A, Allweiss L, Dandri M, Dottermusch M, Heinemann A, Pfefferle S, Schwabenland M, Sumner Magruder D, Bonn S, Prinz M, Gerloff C, P&#xfc;schel K, Krasemann S, Aepfelbacher M, Glatzel M. Neuropathology of patients with COVID-19 in Germany: A post-Mortem case series. The Lancet. Neurology. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, Laue M, Schneider J, Br&#xfc;nink S, Greuel S, Lehmann M, Hassan O, Aschman T, Schumann E, Chua RL, Conrad C, Eils R, Stenzel W, Windgassen M, R&#xf6;&#xdf;ler L, Goebel H-H, Gelderblom HR, Martin H, Nitsche A, Schulz-Schaeffer WJ, Hakroush S, Winkler MS, Tampe B, Scheibe F, K&#xf6;rtv&#xe9;lyessy P, Reinhold D, Siegmund B, K&#xfc;hl AA, Elezkurtaj S, Horst D, Oesterhelweg L, Tsokos M, Ingold-Heppner B, Stadelmann C, Drosten C, Corman VM, Radbruch H, Heppner FL. Olfactory Transmucosal SARS-Cov-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nature Neuroscience. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Melms JC, Biermann J, Huang H, Wang Y, Nair A, Tagore S, Katsyv I, Rendeiro AF, Amin AD, Schapiro D, Frangieh CJ, Luoma AM, Filliol A, Fang Y, Ravichandran H, Clausi MG, Alba GA, Rogava M, Chen SW, Ho P, Montoro DT, Kornberg AE, Han AS, Bakhoum MF, Anandasabapathy N, Su&#xe1;rez-Fari&#xf1;as M, Bakhoum SF, Bram Y, Borczuk A, Guo XV, Lefkowitch JH, Marboe C, Lagana SM, Del Portillo A, Tsai EJ, Zorn E, Markowitz GS, Schwabe RF, Schwartz RE, Elemento O, Saqi A, Hibshoosh H, Que J, Izar B. A molecular single-cell lung Atlas of lethal COVID-19. Nature. 2021;598:114&#x2013;119. doi: 10.1038/s41586-021-03921-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03921-5</ArticleId><ArticleId IdType="pmc">PMC8814825</ArticleId><ArticleId IdType="pubmed">33915568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng KW, Faulkner N, Cornish GH, Rosa A, Harvey R, Hussain S, Ulferts R, Earl C, Wrobel AG, Benton DJ, Roustan C, Bolland W, Thompson R, Agua-Doce A, Hobson P, Heaney J, Rickman H, Paraskevopoulou S, Houlihan CF, Thomson K, Sanchez E, Shin GY, Spyer MJ, Joshi D, O&#x2019;Reilly N, Walker PA, Kjaer S, Riddell A, Moore C, Jebson BR, Wilkinson M, Marshall LR, Rosser EC, Radziszewska A, Peckham H, Ciurtin C, Wedderburn LR, Beale R, Swanton C, Gandhi S, Stockinger B, McCauley J, Gamblin SJ, McCoy LE, Cherepanov P, Nastouli E, Kassiotis G. Preexisting and de novo humoral immunity to SARS-Cov-2 in humans. Science. 2020;370:1339&#x2013;1343. doi: 10.1126/science.abe1107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe1107</ArticleId><ArticleId IdType="pmc">PMC7857411</ArticleId><ArticleId IdType="pubmed">33159009</ArticleId></ArticleIdList></Reference><Reference><Citation>Omololu A, Ojelade B, Ajayi O, Adesomi T, Alade O, Adebisi S, Nwadike V. "Long COVID": A case report of persistent symptoms in a patient with prolonged SARS-Cov-2 shedding for over 110 days. SAGE Open Medical Case Reports. 2021;9:2050313X211015494. doi: 10.1177/2050313X211015494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050313X211015494</ArticleId><ArticleId IdType="pmc">PMC8132077</ArticleId><ArticleId IdType="pubmed">34035919</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Rodrigues H, Hall E, Herrera M, Parikh P, Guevara-Coto J, Triche TJ, Scott P, Hekmati S, Maglinte D, Chang X, Mora-Rodr&#xed;guez RA, Mora J. Persistence of SARS Cov-2 S1 protein in Cd16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Frontiers in Immunology. 2021;12:746021. doi: 10.3389/fimmu.2021.746021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman EA, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. Long-term SARS-Cov-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Reports. 2021;36:109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira C, Harris BHL, Di Giovannantonio M, Rosadas C, Short C-E, Quinlan R, Sureda-Vives M, Fernandez N, Day-Weber I, Khan M, Marchesin F, Katsanovskaja K, Parker E, Taylor GP, Tedder RS, McClure MO, Dani M, Fertleman M. The association between antibody response to severe acute respiratory syndrome Coronavirus 2 infection and post-COVID-19 syndrome in Healthcare workers. The Journal of Infectious Diseases. 2021;223:1671&#x2013;1676. doi: 10.1093/infdis/jiab120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab120</ArticleId><ArticleId IdType="pmc">PMC7989400</ArticleId><ArticleId IdType="pubmed">33675366</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Frontiers in Microbiology. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, L&#xfc;tgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, Liu S, Braun F, Lu S, Pfefferle S, Schr&#xf6;der AS, Edler C, Gross O, Glatzel M, Wichmann D, Wiech T, Kluge S, Pueschel K, Aepfelbacher M, Huber TB. Multiorgan and renal Tropism of SARS-Cov-2. The New England Journal of Medicine. 2020;383:590&#x2013;592. doi: 10.1056/NEJMc2011400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human Coronaviruses. Biochemical and Biophysical Research Communications. 2020;526:135&#x2013;140. doi: 10.1016/j.bbrc.2020.03.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.03.044</ArticleId><ArticleId IdType="pmc">PMC7156119</ArticleId><ArticleId IdType="pubmed">32199615</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebman AW, Aucott JN. Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease. Frontiers in Medicine. 2020;7:57. doi: 10.3389/fmed.2020.00057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00057</ArticleId><ArticleId IdType="pmc">PMC7052487</ArticleId><ArticleId IdType="pubmed">32161761</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, Wen W, Fan X, Hou W, Su B, Cai P, Li J, Liu Y, Tang F, Zhang F, Yang Y, He J, Ma W, He J, Wang P, Cao Q, Chen F, Chen Y, Cheng X, Deng G, Deng X, Ding W, Feng Y, Gan R, Guo C, Guo W, He S, Jiang C, Liang J, Li Y, Lin J, Ling Y, Liu H, Liu J, Liu N, Liu S-Q, Luo M, Ma Q, Song Q, Sun W, Wang G, Wang F, Wang Y, Wen X, Wu Q, Xu G, Xie X, Xiong X, Xing X, Xu H, Yin C, Yu D, Yu K, Yuan J, Zhang B, Zhang P, Zhang T, Zhao J, Zhao P, Zhou J, Zhou W, Zhong S, Zhong X, Zhang S, Zhu L, Zhu P, Zou B, Zou J, Zuo Z, Bai F, Huang X, Zhou P, Jiang Q, Huang Z, Bei J-X, Wei L, Bian X-W, Liu X, Cheng T, Li X, Zhao P, Wang F-S, Wang H, Su B, Zhang Z, Qu K, Wang X, Chen J, Jin R, Zhang Z. COVID-19 immune features revealed by a large-scale single-cell Transcriptome Atlas. Cell. 2021;184:5838. doi: 10.1016/j.cell.2021.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.023</ArticleId><ArticleId IdType="pmc">PMC8582084</ArticleId><ArticleId IdType="pubmed">34767776</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, Garcia-Valtanen P, Al-Delfi Z, Gummow J, Ferguson C, O&#x2019;Connor S, Reddi BAJ, Hissaria P, Shaw D, Kok-Lim C, Gleadle JM, Beard MR, Barry SC, Grubor-Bauk B, Lynn DJ. Long-term perturbation of the peripheral immune system months after SARS-Cov-2 infection. BMC Medicine. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagar M, Reifler K, Rossi M, Miller NS, Sinha P, White LF, Mizgerd JP. Recent Endemic Coronavirus infection is associated with less-severe COVID-19. The Journal of Clinical Investigation. 2021;131:e143380. doi: 10.1172/JCI143380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI143380</ArticleId><ArticleId IdType="pmc">PMC7773342</ArticleId><ArticleId IdType="pubmed">32997649</ArticleId></ArticleIdList></Reference><Reference><Citation>Salou M, Nicol B, Garcia A, Laplaud DA. Involvement of Cd8(+) T cells in multiple sclerosis. Frontiers in Immunology. 2015;6:604. doi: 10.3389/fimmu.2015.00604.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00604</ArticleId><ArticleId IdType="pmc">PMC4659893</ArticleId><ArticleId IdType="pubmed">26635816</ArticleId></ArticleIdList></Reference><Reference><Citation>Sausen DG, Bhutta MS, Gallo ES, Dahari H, Borenstein R. Stress-induced Epstein-Barr virus reactivation. Biomolecules. 2021;11:1380. doi: 10.3390/biom11091380.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11091380</ArticleId><ArticleId IdType="pmc">PMC8470332</ArticleId><ArticleId IdType="pubmed">34572593</ArticleId></ArticleIdList></Reference><Reference><Citation>Seow J, Graham C, Merrick B, Acors S, Pickering S, Steel KJA, Hemmings O, O&#x2019;Byrne A, Kouphou N, Galao RP, Betancor G, Wilson HD, Signell AW, Winstone H, Kerridge C, Huettner I, Jimenez-Guarde&#xf1;o JM, Lista MJ, Temperton N, Snell LB, Bisnauthsing K, Moore A, Green A, Martinez L, Stokes B, Honey J, Izquierdo-Barras A, Arbane G, Patel A, Tan MKI, O&#x2019;Connell L, O&#x2019;Hara G, MacMahon E, Douthwaite S, Nebbia G, Batra R, Martinez-Nunez R, Shankar-Hari M, Edgeworth JD, Neil SJD, Malim MH, Doores KJ. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-Cov-2 infection in humans. Nature Microbiology. 2020;5:1598&#x2013;1607. doi: 10.1038/s41564-020-00813-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-00813-8</ArticleId><ArticleId IdType="pmc">PMC7610833</ArticleId><ArticleId IdType="pubmed">33106674</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F. Structural basis of receptor recognition by SARS-Cov-2. Nature. 2020;581:221&#x2013;224. doi: 10.1038/s41586-020-2179-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2179-y</ArticleId><ArticleId IdType="pmc">PMC7328981</ArticleId><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharova LV, Sharov AA, Nedorezov T, Piao Y, Shaik N, Ko MSH. Database for mRNA half-life of 19 977 genes obtained by DNA Microarray analysis of Pluripotent and differentiating mouse embryonic stem cells. DNA Research. 2009;16:45&#x2013;58. doi: 10.1093/dnares/dsn030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/dnares/dsn030</ArticleId><ArticleId IdType="pmc">PMC2644350</ArticleId><ArticleId IdType="pubmed">19001483</ArticleId></ArticleIdList></Reference><Reference><Citation>Simula ER, Manca MA, Noli M, Jasemi S, Ruberto S, Uzzau S, Rubino S, Manca P, Sechi LA. Increased presence of antibodies against type I Interferons and human endogenous Retrovirus W in intensive care unit COVID-19 patients. Microbiology Spectrum. 2022;10:e0128022. doi: 10.1128/spectrum.01280-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01280-22</ArticleId><ArticleId IdType="pmc">PMC9430400</ArticleId><ArticleId IdType="pubmed">35852349</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, Lu P, Weizman O-E, Liu F, Dai Y, Szigeti-Buck K, Yasumoto Y, Wang G, Castaldi C, Heltke J, Ng E, Wheeler J, Alfajaro MM, Levavasseur E, Fontes B, Ravindra NG, Van Dijk D, Mane S, Gunel M, Ring A, Kazmi SAJ, Zhang K, Wilen CB, Horvath TL, Plu I, Haik S, Thomas J-L, Louvi A, Farhadian SF, Huttner A, Seilhean D, Renier N, Bilguvar K, Iwasaki A. Neuroinvasion of SARS-Cov-2 in human and mouse brain. The Journal of Experimental Medicine. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, Pavlovitch-Bedzyk AJ, Dong S, Lausted C, Lee I, Fallen S, Dai CL, Baloni P, Smith B, Duvvuri VR, Anderson KG, Li J, Yang F, Duncombe CJ, McCulloch DJ, Rostomily C, Troisch P, Zhou J, Mackay S, DeGottardi Q, May DH, Taniguchi R, Gittelman RM, Klinger M, Snyder TM, Roper R, Wojciechowska G, Murray K, Edmark R, Evans S, Jones L, Zhou Y, Rowen L, Liu R, Chour W, Algren HA, Berrington WR, Wallick JA, Cochran RA, Micikas ME, Wrin T, Petropoulos CJ, Cole HR, Fischer TD, Wei W, Hoon DSB, Price ND, Subramanian N, Hill JA, Hadlock J, Magis AT, Ribas A, Lanier LL, Boyd SD, Bluestone JA, Chu H, Hood L, Gottardo R, Greenberg PD, Davis MM, Goldman JD, Heath JR, ISB-Swedish COVID-19 Biobanking Unit Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W, Huang N, B&#xe9;cavin C, Berg M, Queen R, Litvinukova M, Talavera-L&#xf3;pez C, Maatz H, Reichart D, Sampaziotis F, Worlock KB, Yoshida M, Barnes JL, HCA Lung Biological Network SARS-Cov-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nature Medicine. 2020;26:681&#x2013;687. doi: 10.1038/s41591-020-0868-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, Walt DR. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clinical Infectious Diseases. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan PH, Ji J, Hsing CH, Tan R, Ji RR. Emerging roles of type-I Interferons in Neuroinflammation, neurological diseases, and long-haul COVID. International Journal of Molecular Sciences. 2022;23:14394. doi: 10.3390/ijms232214394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232214394</ArticleId><ArticleId IdType="pmc">PMC9696119</ArticleId><ArticleId IdType="pubmed">36430870</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F, Catalan P, Rodriguez-Grande C, Adan J, Rodriguez-Gonzalez C, Mu&#xf1;oz P, Aldamiz T, Diez C, Perez L, Fanciulli C, Garcia de Viedma D, Gregorio Mara&#xf1;on Microbiology ID COVID 19 Study Group Post-COVID-19 syndrome. SARS-Cov-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infectious Diseases. 2022;22:211. doi: 10.1186/s12879-022-07153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Temerozo JR, Fintelman-Rodrigues N, Dos Santos MC, Hottz ED, Sacramento CQ, de Paula Dias da Silva A, Mandacaru SC, Dos Santos Moraes EC, Trugilho MRO, Gesto JSM, Ferreira MA, Saraiva FB, Palhinha L, Martins-Gon&#xe7;alves R, Azevedo-Quintanilha IG, Abrantes JL, Righy C, Kurtz P, Jiang H, Tan H, Morel C, Bou-Habib DC, Bozza FA, Bozza PT, Souza TML. Human endogenous Retrovirus K in the respiratory tract is associated with COVID-19 Physiopathology. Microbiome. 2022;10:65. doi: 10.1186/s40168-022-01260-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-022-01260-9</ArticleId><ArticleId IdType="pmc">PMC9024070</ArticleId><ArticleId IdType="pubmed">35459226</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsch&#xf6;pe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, Hare JM, Heidecker B, Heymans S, H&#xfc;bner N, Kelle S, Klingel K, Maatz H, Parwani AS, Spillmann F, Starling RC, Tsutsui H, Seferovic P, Van Linthout S. Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions. Nature Reviews. Cardiology. 2021;18:169&#x2013;193. doi: 10.1038/s41569-020-00435-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00435-x</ArticleId><ArticleId IdType="pmc">PMC7548534</ArticleId><ArticleId IdType="pubmed">33046850</ArticleId></ArticleIdList></Reference><Reference><Citation>van Nierop GP, Mautner J, Mitterreiter JG, Hintzen RQ, Verjans GMGM. Intrathecal Cd8 T-cells of multiple sclerosis patients recognize Lytic Epstein-Barr virus proteins. Multiple Sclerosis. 2016;22:279&#x2013;291. doi: 10.1177/1352458515588581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458515588581</ArticleId><ArticleId IdType="pubmed">26041797</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm LK, Nielsen SSF, Pahus MH, Frattari GS, Olesen R, Andersen R, Monrad I, Andersen AHF, Thomsen MM, Konrad CV, Andersen SD, H&#xf8;jen JF, Gunst JD, &#xd8;stergaard L, S&#xf8;gaard OS, Schleimann MH, Tolstrup M. SARS-Cov-2 persistence is associated with antigen-specific Cd8 T-cell responses. EBioMedicine. 2021;64:103230. doi: 10.1016/j.ebiom.2021.103230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103230</ArticleId><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L, Hanson B, Orban Z, Lim PH, Palacio NM, Jain R, Clark JR, Graham EL, Liotta EM, Penaloza-MacMaster P. Neuro-COVID long-haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination. medRxiv. 2021 doi: 10.1101/2021.08.08.21261763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.08.08.21261763</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg SP, Ural BB, Farber DL. Tissue-specific immunity for a changing world. Cell. 2021;184:1517&#x2013;1529. doi: 10.1016/j.cell.2021.01.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.042</ArticleId><ArticleId IdType="pmc">PMC7988978</ArticleId><ArticleId IdType="pubmed">33740452</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson HW, Amo-Addae M, Kenu E, Ilesanmi OS, Ameme DK, Sackey SO. Post-Ebola syndrome among Ebola virus disease survivors in Montserrado County, Liberia 2016. BioMed Research International. 2018;2018:1909410. doi: 10.1155/2018/1909410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/1909410</ArticleId><ArticleId IdType="pmc">PMC6046154</ArticleId><ArticleId IdType="pubmed">30050920</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xf6;lfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, M&#xfc;ller MA, Niemeyer D, Jones TC, Vollmar P, Rothe C, Hoelscher M, Bleicker T, Br&#xfc;nink S, Schneider J, Ehmann R, Zwirglmaier K, Drosten C, Wendtner C. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;588:465&#x2013;469. doi: 10.1038/s41586-020-2984-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2984-3</ArticleId><ArticleId IdType="pubmed">32235945</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Zhou Y, Cai L, Wang L, Han J, Yang X, Chen J, Chen J, Ma C, Shen L. Co-reactivation of the human Herpesvirus alpha Subfamily (herpes Simplex Virus-1 and Varicella Zoster virus) in a critically ill patient with COVID-19. The British Journal of Dermatology. 2020;183:1145&#x2013;1147. doi: 10.1111/bjd.19484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.19484</ArticleId><ArticleId IdType="pmc">PMC7436688</ArticleId><ArticleId IdType="pubmed">32790074</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yasuhara A, Ito M, Akasaka O, Nakamura M, Nakachi I, Koga M, Mitamura K, Yagi K, Maeda K, Kato H, Nojima M, Pattinson D, Ogura T, Baba R, Fujita K, Nagai H, Yamamoto S, Saito M, Adachi E, Ochi J, Hattori S-I, Suzuki T, Miyazato Y, Chiba S, Okuda M, Murakami J, Hamabata T, Iwatsuki-Horimoto K, Nakajima H, Mitsuya H, Omagari N, Sugaya N, Yotsuyanagi H, Kawaoka Y. Antibody titers against SARS-Cov-2 decline, but do not disappear for several months. EClinicalMedicine. 2021;32:100734. doi: 10.1016/j.eclinm.2021.100734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100734</ArticleId><ArticleId IdType="pmc">PMC7877219</ArticleId><ArticleId IdType="pubmed">33589882</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-Cov-2 by full-length human Ace2. Science. 2020;367:1444&#x2013;1448. doi: 10.1126/science.abb2762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, Fehlmann T, Stein JA, Schaum N, Lee DP, Calcuttawala K, Vest RT, Berdnik D, Lu N, Hahn O, Gate D, McNerney MW, Channappa D, Cobos I, Ludwig N, Schulz-Schaeffer WJ, Keller A, Wyss-Coray T. Publisher correction: dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;598:E4. doi: 10.1038/s41586-021-04080-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04080-3</ArticleId><ArticleId IdType="pmc">PMC8500262</ArticleId><ArticleId IdType="pubmed">34625744</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid A, G&#xe9;rardin P, Taylor A, Mostafavi H, Malvy D, Mahalingam S. Chikungunya arthritis: Implications of acute and chronic inflammation mechanisms on disease management. Arthritis &amp; Rheumatology. 2018;70:484&#x2013;495. doi: 10.1002/art.40403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40403</ArticleId><ArticleId IdType="pubmed">29287308</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, Xu Y, Tian Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cellular &amp; Molecular Immunology. 2020;17:533&#x2013;535. doi: 10.1038/s41423-020-0402-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0402-2</ArticleId><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, Pfister A, Meyer M, R&#xf6;ssler A, Kimpel J, Adolph TE, Tilg H. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163:495&#x2013;506. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>